Nicklas Westerholm
Fortuna: 330 238 $ al 31/05/2026
Fortuna: 330 238 $ al 31/05/2026
Nicklas Westerholm is currently Chief Executive Officer at Egetis Therapeutics AB since 2017, Chairman & Chief Executive Officer at Rare Thyroid Therapeutics International AB, and Independent Director at Spago Nanomedical AB since 2019.
Former positions include Head-Investor Relations at AstraZeneca PLC from 2011 to 2013 and VP-Project & Portfolio Management at AstraZeneca AB from 1995 to 2017.
Education includes undergraduate studies at the University of Stockholm and the Royal Institute of Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EGETIS THERAPEUTICS AB 0,11 % | 13/05/2026 | 501.508 ( 0,11 % ) | 330 238 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EGETIS THERAPEUTICS AB | Director Ejecutivo | 16/06/2017 |
| SPAGO NANOMEDICAL AB | Director/Miembro de la Junta | 08/05/2019 |
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Provides thyroid therapeutics research services | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | 01/06/2017 |
| ASTRAZENECA PLC | Contacto de Relaciones con Inversores | 08/09/2011 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Stockholm
University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Institute of Technology
Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Egetis Therapeutics AB
Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Spago Nanomedical AB
Spago Nanomedical AB BiotechnologyHealth Technology Acts as a biotechnology company | Health Technology |
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Provides thyroid therapeutics research services | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.